Parallax Volatility Advisers, L.P. Mirati Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $965,971 - $1.32 Million	26,736 Added 105.88%	51,988 $1.88 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $202,212 - $300,274	5,534 Added 28.07%	25,252 $938,000
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $524,706 - $1.25 Million	-12,714 Reduced 39.2%	19,718 $893,000
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $2.56 Million - $3.73 Million	-43,010 Reduced 57.01%	32,432 $2.27 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $2.83 Million - $6.42 Million	72,362 Added 2349.42%	75,442 $5.06 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $326,460 - $470,587	-2,473 Reduced 44.53%	3,080 $452,000
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $801,013 - $1.19 Million	4,943 Added 810.33%	5,553 $1.22 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $8.38 Million - $15.3 Million	-118,444 Reduced 99.49%	610 $79,000
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $203,267 - $285,946	2,609 Added 2.24%	119,054 $9.28 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $6.33 Million - $11.1 Million	106,445 Added 1064.45%	116,445 $12 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $436,500 - $789,500	10,000 New	10,000 $733,000
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $4,427 - $6,650	-350 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $1,645 - $4,094	350	350 $4,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.